Proprietary AI analyst is now available

Klon Valuation Multiples

Discover revenue and EBITDA valuation multiples for Klon and similar public comparables like Koszalinskie Przedsiebiorstwo Przemyslu Drzewnego, EO2, Proteak, Standrew and more.

Klon Overview

About Klon

Klon SA is engaged in producing and supplying beech, oak, birch, and alder non-cut off and cut off timber products. The company also provides tri, multilayer, and micro-insert deciduous board products and upholstered furniture and carved elements. It sells products in Poland and the rest of the world.


Founded

1991

HQ

Poland

Employees

67

Financials (FY)

Revenue: $5M
EBITDA: ($544K)

EV

$9M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Klon Financials

Klon reported last fiscal year revenue of $5M and negative EBITDA of ($544K).

In the same fiscal year, Klon generated $1M in gross profit, ($544K) in EBITDA losses, and had net loss of ($1M).


Klon P&L

In the most recent fiscal year, Klon reported revenue of $5M and EBITDA of ($544K).

Klon is unprofitable as of last fiscal year, with gross margin of 23%, EBITDA margin of (11%), and net margin of (21%).

See analyst estimates for Klon
Last FY202320242025202620272028
Revenue$5M$7M$6M$5M
Gross Profit$1M$3M$2M$1M
Gross Margin23%45%31%23%
EBITDA($544K)$723K($459K)($544K)
EBITDA Margin(11%)11%(7%)(11%)
EBIT Margin(20%)0%(16%)(20%)
Net Profit($1M)($26K)($1M)($1M)
Net Margin(21%)(0%)(17%)(21%)
Net Debt$1M---

Financial data powered by Morningstar, Inc.

Klon Stock Performance

Klon has current market cap of $8M, and enterprise value of $9M.

Market Cap Evolution


Klon's stock price is $0.35.

Klon share price decreased by 8.2% in the last 30 days, and by 3.1% in the last year.

Klon has an EPS (earnings per share) of $-0.04.

See more trading valuation data for Klon
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$9M$8M0.0%-8.2%5.1%-3.1%$-0.04

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Klon Valuation Multiples

Klon trades at 1.8x EV/Revenue multiple, and (16.6x) EV/EBITDA.

See NTM and 2027E valuation multiples for Klon

Klon Financial Valuation Multiples

As of June 14, 2026, Klon has market cap of $8M and EV of $9M.

Klon has a P/E ratio of (7.9x).

Last FY202320242025202620272028
EV/Revenue1.8x1.4x1.4x1.8x
EV/EBITDA(16.6x)12.5x(19.7x)(16.6x)
EV/EBIT(8.9x)n/m(8.9x)(8.9x)
EV/Gross Profit7.8x3.1x4.5x7.8x
P/E(7.9x)n/m(7.8x)(7.9x)
EV/FCF(20.0x)(223.3x)n/m(20.0x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Klon Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Klon Margins & Growth Rates

In the most recent fiscal year, Klon reported gross margin of 23%, EBITDA margin of (11%), and net margin of (21%).

See estimated margins and future growth rates for Klon

Klon Margins

Last FY20242025202720282029
Gross Margin23%31%23%
EBITDA Margin(11%)(7%)(11%)
EBIT Margin(20%)(16%)(20%)
Net Margin(21%)(17%)(21%)
FCF Margin(9%)(1%)(9%)

Klon Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(4%)(21%)
Gross Profit Growth(33%)(42%)
EBITDA Growth(164%)18%
EBIT Growth(4244%)(0%)
Net Profit Growth4019%(2%)
FCF Growth(14%)1200%

Data powered by FactSet, Inc. and Morningstar, Inc.

Klon Operational KPIs

Klon's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

Access forward-looking KPIs for Klon
Last FY202320242025202620272028
Revenue per Employee$0.1M---
Opex per Employee$0.0M---
Opex to Revenue43%44%47%43%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Koszalinskie Przedsiebiorstwo Przemyslu Drzewnego0.1x-19.5x-
EO20.5x-4.0x-
Proteak3.6x-14.5x-
Standrew2.1x-17.9x-
Embpar Participacoes8.9x-(14.0x)-
Werth-Holz0.9x-(61.3x)-
KHD Humboldt Wedag--11.0x-
Fazerles0.2x-(3.3x)-

This data is available for Pro users. Sign up to see all Klon competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Klon

When was Klon founded?Klon was founded in 1991.
Where is Klon headquartered?Klon is headquartered in Poland.
How many employees does Klon have?As of today, Klon has over 67 employees.
Is Klon publicly listed?Yes, Klon is a public company listed on Warsaw Stock Exchange.
What is the stock symbol of Klon?Klon trades under KLN ticker.
When did Klon go public?Klon went public in 2011.
Who are competitors of Klon?Klon main competitors include Koszalinskie Przedsiebiorstwo Przemyslu Drzewnego, EO2, Proteak, Standrew, Embpar Participacoes, Werth-Holz, KHD Humboldt Wedag, Fazerles, Interwood-Xylemporia, Rougier.
What is the current market cap of Klon?Klon's current market cap is $8M.
What is the current revenue of Klon?Klon's last fiscal year revenue is $5M.
What is the current EV/Revenue multiple of Klon?Current revenue multiple of Klon is 1.8x.
Is Klon profitable?No, Klon is not profitable.
How many companies Klon has acquired to date?Klon hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Klon has invested to date?Klon hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Klon

Lists including Klon

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial